Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Capital Expenditures (2024 - 2025)

Historic Capital Expenditures for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $1.3 million.

  • Beta Bionics' Capital Expenditures fell 3173.59% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $3.4 million for FY2024, which is 74452.74% up from last year.
  • Per Beta Bionics' latest filing, its Capital Expenditures stood at $1.3 million for Q3 2025, which was down 3173.59% from $1.4 million recorded in Q2 2025.
  • Over the past 5 years, Beta Bionics' Capital Expenditures peaked at $1.9 million during Q3 2024, and registered a low of $406000.0 during Q1 2024.